MENLO
PARK, Calif., Nov. 9, 2023
/PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of
high-quality, highly accurate sequencing solutions, announced today
that management will be participating in the following upcoming
investor conferences:
- Canaccord Genuity MedTech, Diagnostics and Digital Health &
Services Forum on Thursday, November 16,
2023, at 2:00 PM ET in
New York, NY
- Piper Sandler 35th Annual Healthcare Conference on
Tuesday, November 28, 2023, at
3:00 PM ET in New York, NY
Live webcasts of the events can be accessed at the company's
investors page at investor.pacificbiosciences.com. Webcast replays
will be available for at least 30 days following the event.
About PacBio
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier
life science technology company that is designing, developing, and
manufacturing advanced sequencing solutions that enable scientists
and clinical researchers to improve their understanding of the
genome and ultimately, resolve genetically complex problems. Our
products and technology under development stem from two highly
differentiated core technologies focused on accuracy, quality, and
completeness, which include our existing HiFi long-read sequencing
technology and our emerging short-read Sequencing by Binding (SBB™)
technology. Our products address solutions across a broad set of
applications, including human genomics, plant and animal sciences,
infectious disease and microbiology, oncology, and other emerging
applications. For more information, please visit www.pacb.com and
follow @PacBio.
PacBio products are provided for research use only. Not for use
in diagnostic procedures.
Contacts
Investors:
Todd
Friedman
650.521.8450
ir@pacb.com
Media:
Lizelda Lopez
pr@pacb.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/pacbio-to-present-at-upcoming-investor-conferences-301984021.html
SOURCE Pacific Biosciences of California, Inc.